Involvement of retrotransposon L1 in stemness and cellular plasticity

References

• Kalluri R, Weinberg RA (2009). The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Weinberg RA (2011). A perspective on cancer cell metastasis. Science. 331:1559–1564.
   PubMed Web of Science ®Google Scholar
• Lee JM, Dedhar S, Kalluri R, Thompson EW (2006). The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 172:973–981.
   PubMed Web of Science ®Google Scholar
• Toloudi M, Apostolou P, Chatziioannou M, Papasotiriou I (2011). Correlation between Cancer Stem Cells and Circulating Tumor Cells and Their Value. Case Rep Oncol. 4:44–54.
   PubMedGoogle Scholar
• Lander ES, Linton LM, Birren B et al (2001). Initial sequencing and analysis of the human genome. Nature. 409:860–921.
   PubMed Web of Science ®Google Scholar
• Feng Q, Moran JV, Kazazian HH, Jr., Boeke JD (1996). Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell. 87:905–916.
   PubMed Web of Science ®Google Scholar
• Munz M, Baeuerle PA, Gires O (2009). The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 69:5627–5629.
   PubMed Web of Science ®Google Scholar
• Chiou SH, Yu CC, Huang CY et al (2008). Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res. 14:4085–4095.
   PubMed Web of Science ®Google Scholar
• Xiang R, Liao D, Cheng T et al (2011). Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer. 104:1410–1417.
   PubMed Web of Science ®Google Scholar
• Janikova M, Skarda J, Dziechciarkova M et al (2010). Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 154:321–326.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
   PubMed Web of Science ®Google Scholar
• Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A (2004). Rational siRNA design for RNA interference. Nat Biotechnol. 22:326–330.
   PubMed Web of Science ®Google Scholar
• Tang SN, Fu J, Nall D, Rodova M, Shankar S, Srivastava RK (2012). Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics. Int J Cancer. 131:30–40.
   PubMed Web of Science ®Google Scholar
• Mani SA, Guo W, Liao MJ et al (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704–715.
   PubMed Web of Science ®Google Scholar
• Wellner U, Schubert J, Burk UC et al (2009). The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 11:1487–1495.
   PubMed Web of Science ®Google Scholar
• Tomaskovic-Crook E, Thompson EW, Thiery JP (2009). Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res. 11:213.
   PubMed Web of Science ®Google Scholar
• Sipos F, Galamb O (2012). Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon. World J Gastroenterol. 18:601–608.
   PubMed Web of Science ®Google Scholar
• Radisky DC (2005). Epithelial-mesenchymal transition. J Cell Sci. 118:4325–4326.
   PubMed Web of Science ®Google Scholar
• Chueh AC, Northrop EL, Brettingham-Moore KH, Choo KH, Wong LH (2009). LINE retrotransposon RNA is an essential structural and functional epigenetic component of a core neocentromeric chromatin. PLoS Genet. 5:e1000354.
   PubMed Web of Science ®Google Scholar
• Belgnaoui SM, Gosden RG, Semmes OJ, Haoudi A (2006). Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells. Cancer Cell Int. 6:13.
   PubMed Web of Science ®Google Scholar
• Chen L, Dahlstrom JE, Chandra A, Board P, Rangasamy D (2012). Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer. Breast Cancer Res Treat. 136:129–142
   PubMed Web of Science ®Google Scholar
• Tsutsumi Y (2000). Hypomethylation of the retrotransposon LINE-1 in malignancy. Jpn J Clin Oncol. 30:289–290.
   PubMed Web of Science ®Google Scholar
• Tchenio T, Casella JF, Heidmann T (2000). Members of the SRY family regulate the human LINE retrotransposons. Nucleic Acids Res. 28:411–415.
   PubMed Web of Science ®Google Scholar
• Leis O, Eguiara A, Lopez-Arribillaga E, et al (2012). Sox2 expression in breast tumours and activation in breast cancer stem cells. Oncogene. 31:1354–1365.
   PubMed Web of Science ®Google Scholar
• Rodda DJ, Chew JL, Lim LH, et al (2005). Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem. 280:24731–24737.
   PubMed Web of Science ®Google Scholar
• Carreira PE, Richardson SR, Faulkner GJ (2014). L1 retrotransposons, cancer stem cells and oncogenesis. FEBS J. 281:63–73.
   PubMed Web of Science ®Google Scholar
• Ramos KS, Montoya-Durango DE, Teneng I, Nanez A, Stribinskis V (2011). Epigenetic control of embryonic renal cell differentiation by L1 retrotransposon. Birth Defects Res A Clin Mol Teratol. 91:693–702.
   PubMed Web of Science ®Google Scholar
• Batlle E, Sancho E, Franci C et al (2000). The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2:84–89.
   PubMed Web of Science ®Google Scholar